J&J last month recently reported favorable results from a Phase 2 study of TAR-200 plus cetrelimab in patients with muscle-invasive bladder cancer who are ineligible or refuse neoadjuvant ...

Pharma stock Theralase Technologies (TSXV:TLT) announced a significant update on its ongoing bladder cancer clinical study ...

In response to the FDA request, there is a demonstrated duration of CR of 13.2% (9/68) at 540 days, 8.8% (6/68) at 630 days, 7.4% (5/68) at 720 days, 7.4% (5/68) at 900 days and 5.9% (4/68) at 1080 ...

Older women suffering from urine incontinence can benefit from frequent, low-impact exercise, including yoga, stretching, and ...

Pelvic floor muscles are like the unsung heroes of your body. You don’t really think about them until they start acting up, ...